XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Dividends Declared and Paid

During the nine months ended September 30, 2022, we declared and paid the following cash dividends (amount declared and amount paid in thousands):

Declaration Date						Record Date						Payment Date						Dividend Per Share						Amount Declared						Amount Paid
2/24/2022						3/15/2022						3/31/2022						$	0.90					$	26,585					$	26,242
2/24/2022						3/15/2022						3/31/2022						0.315						9,305						9,184
5/5/2022						6/15/2022						6/30/2022						0.315						9,054						8,982
8/4/2022						9/15/2022						9/30/2022						0.315						9,018						8,945

During the nine months ended September 30, 2021, we declared and paid the following cash dividends (amount declared and amount paid in thousands):

Declaration Date						Record Date						Payment Date						Dividend Per Share						Amount Declared						Amount Paid
2/23/2021						3/15/2021						3/31/2021						$	0.30					$	8,907					$	8,786
5/5/2021						6/15/2021						6/30/2021						0.30						8,910						8,821
8/5/2021						9/15/2021						9/30/2021						0.30						8,912						8,821

Derivative Instruments, Gain (Loss)

The following table summarizes amounts recorded to interest expense, net included in the Condensed Consolidated Statements of Operations and Comprehensive Income related to our interest rate swaps (in thousands):

			Three months ended September 30,												Nine months ended September 30,
			2022						2021						2022						2021
(Benefit) expense associated with swap net settlements			$	(1,303)					$	147					$	(344)					$	147
Expense associated with amortization of terminated swaps			1,127						812						2,796						2,412

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

The change in accumulated other comprehensive income (loss) related to our interest rate derivatives, net of taxes, was as follows (in thousands):

						Three months ended September 30,												Nine months ended September 30,
						2022						2021						2022						2021
Accumulated gain/(loss) at beginning of period						$	28,034					$	(2,293)					$	(227)					$	(8,763)
Unrealized gains in fair value						13,547						691						40,577						5,960
Reclassifications of realized net losses to earnings						832						601						2,063						1,802
Accumulated gain/(loss) at end of period						42,413						(1,001)						42,413						(1,001)

X

- Definition

Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.

+ References

No definition available.

+ Details

Name:	us-gaap_DividendsDeclaredTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959

+ Details

Name:	us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration